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Abstract
Background:  Endometrial  cancer  is  one  of  the  most  common 
types  of  gynecologic  cancers. The  ability of  exercise to  reduce 
the risk of endometrial cancer in women with type 2 diabetes has 
been established, but no studies have examined this link in type 1 
diabetes.A randomized, controlled animal study was designed using 
a standard rat model of type 1 diabetes. The goal of this study was 
to investigate the ability of exercise to prevent  increased levels of 
endometrial cancer biomarkers, estrogen receptor (ERα) and p16, 
and endometrial hyperplasia associated with diabetes.   
    
Methods: Forty female rats were randomized into four groups: 
sedentary control, exercise control, sedentary or exercised diabetic.   
Diabetes  was  induced  by  alloxan  injection. A  4-week  treadmill 
training program was initiated with the development of diabetes. 
Endometrial tissues were evaluated for hyperplasia and ERα and 
p16 levels and subcellular localization using microscopy.
Results: Severe diabetes lead to hyperplasia in the endometrial tis-
sue in 70% of sedentary diabetic rats. Exercise-trained diabetic rats 
and the non-diabetic rats displayed no hyperplasia. The expression 
of ERα increased significantly (p < 0.02) while the expression level 
of p16 decreased significantly (p < 0.04) in the diabetic sedentary 
group compared to the non-diabetic groups.  Exercise training led 
to a reversal in the percentage of p16 and ERα positive cells in 
diabetic rats. 
Conclusions: Severe diabetes leads to hyperplasia of the endome-
trial tissue and increased ERα levels and decreased p16 levels in 
rats, which can be prevented with aerobic exercise.
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Introduction
Endometrial cancer is the fourth most common type of can-
cer among women and the most common gynecologic cancer 
[1, 2]. Twenty-two percent of woman who have had endome-
trial cancer will experience recurrences [3]. Most startling, 
endometrial cancer incidence and mortality rates are on the 
rise in spite of the fact that most cases are diagnosed at early 
stages [4]. Although the exact cause of endometrial cancer 
is unknown, there are many factors that increase the risk of 
endometrial cancer, including chronic diseases such as dia-
betes [5, 6]. Most studies have focused on the link between 
type 2 diabetes and endometrial cancer, finding that the risk 
of endometrial cancer rises with greater levels of obesity [7, 
8]. However, this association has not always been clear as 
one study reported that a body mass index (BMI) of greater 
than 35 was not associated with endometrial cancer, while 
a lower BMI was associated [6]. A prospective study ana-
lyzing 24,000 post-menopausal women found that diabetes, 
independent of obesity, was associated with an increase in 
the risk of endometrial cancer [8]. It has been hypothesized 
that changes in insulin levels may be part of the link between 
diabetes and cancer [9].
    While the link between obesity, type 2 diabetes and endo-
metrial cancer has been studied extensively, few studies have 
focused on the link between the autoimmune form of diabe-
tes, type 1 diabetes, and endometrial cancer [10]. Those that 
have looked at the risk and prognosis of endometrial cancer 
specifically in women with type 1 diabetes have determined 
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that there is an association [10-12]. Zendehel et al. studied 
the increased risk for all cancer in people with type 1 diabe-
tes.  They found that people with type 1 diabetes had elevat-
ed risks of cancers of the stomach, cervix and endometrium 
[13]. Clearly, there is a need for more controlled studies that 
specifically examine the mechanistic link between diabetes 
and endometrial cancer [14].
In  2001,  the  International  Agency  for  Research  on 
Cancer published a report concluding that physical activity 
could reduce the risk of endometrial cancer [15]. Some of 
the most important data suggests that sedentary behavior is 
a risk factor for endometrial cancer that is independent of 
obesity [16]. Such studies also suggest that women who are 
physically active have a 20 percent reduced risk of endome-
trial cancer [17]. The current study is the first to focus on the 
molecular changes that occur in the endometrium using an 
animal model of type 1 diabetes. The purpose of this study 
was to determine whether there was a change in biomarkers 
for endometrial cancer in an animal model of type 1 diabetes.   
The effects of exercise, an intervention known to significant-
ly lower the risk of endometrial cancer in women [17-19], 
was tested to determine whether it could prevent early endo-
metrial changes in animals with type 1 diabetes.
Materials and Methods
Animals
Eight-week old Sprague-Dawley female rats were used in 
this study and randomly assigned into one of four groups. 
Sedentary control (SC, n = 10), exercise control (EC, n = 
10), sedentary diabetic (SD, n = 10), exercise diabetic (ED, 
n = 10).  Animals were housed in individual cages at a 22 
± 1°C in a controlled room with a 12:12 light: dark cycle. 
The animals were allowed free access to standard chow and 
water. All experiments were performed in accordance with 
the institutional research committee guidelines for animal 
experimentation.
           Rats in the two diabetic groups received an intraperito-
neal injection of alloxan (120 mg/kg) or saline in the control 
groups. Three days later, a confirmation of successful induc-
tion of diabetes was assessed by demonstration of hypergly-
cemia in the rats. Animals with fasting blood glucose above 
250 mg/dl were classified as diabetic animals.
Animal  Care  and  Use  Committee Approval  obtained 
from the Jordanian University of Science and Technology.
Exercise protocol 
The exercise training protocol utilized was based on previ-
ous publications providing evidence of adequate systemic 
and cellular adaptations with this level of aerobic exercise 
[20, 21]. Aerobic exercise training was conducted on a cus-
tom treadmill with 8 separate lanes. Following the alloxan or 
saline treatment, the rats in the exercised groups were intro-
duced to the treadmill slowly over the course of a week with 
initial orientation and walking on the moving treadmill. The 
4 week exercise protocol did not begin until rats could run at 
a speed of 18 m/min. The training protocol was individual-
ized for each animal, but in general consisted of running for 
40 min/day for 5 days/week at a speed of 18 m/min. Seden-
tary rats did not exercise; however, they were transported 
daily to the training room so that they were exposed to the 
same environment as the exercised groups of animals.
 
Immunostaining of p16 and estrogen receptor (ERα) in 
the endometrium
Tissues were collected from the stromal and epithelial re-
gions and fixed in 4% parafolmaldehyde and subsequently 
embedded in paraffin. Sections (3 - 4 µm) were mounted 
on coated slides (microslides sc-24976, Santa Cruz). Prior 
to staining, samples were deparaffinized in xylene twice for 
2 minutes, then rehydrated through serial dilutions of alco-
hol (100%, 90%, 80%, and 70%) ending in water (2 minutes 
each step). This was followed by treatment under pressure 
in the reveal solution (RV1000M, Biocare Medical, Con-
cord, CA) for 2 minutes in the Decloaking chamber (Biocare 
Medical) in order to retrieve the antigens, and later to block 
endogenous biotin. After cooling to room temperature, sec-
tions were incubated with 3% hydrogen peroxide in meth-
anol in order to block the endogenous peroxidase activity 
for 5 minutes and then were washed in phosphate buffered 
saline (PBS). According to the manufacturer’s instructions, 
sections were incubated for 1 hour at room temperature with 
ERα (Santa Cruz Biotechnology, Santa Cruz, CA) and p16 
(Biocare Medical, San Antonio, TX) antibodies which were 
diluted according to vendor instructions. Subsequently sec-
tions were washed in PBS and incubated with biotinylated 
secondary antibody (LSAB kit, Dako Carpinteria, CA) for 
15 minutes at room temperature, then washed with PBS. 
Sections were incubated with streptavidin horse radish per-
oxidase (LSAB kit, Dako) for 15 minutes at room tempera-
ture and washed with PBS. 3,3’-Diaminobenzidine (DAB) 
substrate was applied for 2 minutes or longer, until the de-
sired color intensity was developed, and then the slides were 
washed with tap water to stop the reaction. Throughout the 
study, sections from normal human endometrium known to 
express the investigated proteins were analyzed in parallel 
to serve as positive controls. Omission of the primary an-
tibody from these samples served as negative controls. All 
sections were counterstained with hematoxylin and exam-
ined by light microscopy. Ten slides from each animal group 
were evaluated for p16 and ERα expression by two blinded 
independent evaluators. The area labeled with specific an-
tibody and the percentage of cells positive for the antigen 
were calculated using published procedures [22]. The evalu-
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ation of immunostaining of ERα and p16 was performed on 
both the stromal and epithelial components, but only statisti-
cal analysis of the stromal regions were reported. Findings 
in the epithelial regions presented with wide variability that 
failed to show statistically significant differences.
Examination of tissue pathology
Ten slides were randomly assigned for histopathology evalu-
ation from each group of animals. Haematoxylene and Eo-
sin staining was done using standard protocol. Two double 
blinded pathologists evaluated the sections for estrous cycle 
stage and indications of hyperplasia from the four experi-
mental groups. The hyperplasia was evaluated and graded 
using standard procedures according to the number, crowd-
ing and complexity of glands, the glands to stroma ratio, and 
epithelial atypia [23].
 
Data analysis
One way ANOVA was completed on all animals followed 
by paired and unpaired student t-test analysis to determine 
statistical significance within each group and to compare two 
groups.  Kruskal-Wallis One Way ANOVA on Ranks was 
completed for histological analysis of glandular formation 
followed by a Dunn’s Test.  Differences at p value < 0.05 
were considered statistically significant.
 
Results
Animal characteristics 
As expected, the 8-week old rats continued to grow after the 
induction of diabetes. There was no statistically significant 
difference in the percentage of gained weight for any group, 
which ranged from 7 to 17% increase from their initial body 
weight (Table 1). At the completion of the study, rats from 
the two diabetic groups had significantly higher blood glu-
cose levels than the two control groups (p < 0.001, Table 1). 
Interestingly, the diabetic rats that ran on the treadmill had a 
significantly lower blood glucose level at the termination of 
the study than the sedentary diabetic rats (p < 0.001, Table 
1).
Expression of ERα in the endometrium
Estrogen receptor (ERα) levels have been shown to be highly 
correlated with gynecological cancers, and have been sug-
gested as simple screening mechanism for high risk patients 
 
          Group
  
Initial Weight (g)
 
Final Weight (g)
 
Blood glucose (mg/dl)
 
Sedentary Control (SC)
     
     120 ± 11
      
     143 ± 8
       
      104 ± 6
Exercise Control (EC)      131 ± 12      158 ± 13         94 ± 9
Sedentary Diabetic (SD)      125 ± 10      134 ± 7       430 ± 13*
Exercise Diabetic (ED)      128 ± 11      152 ± 12       237 ± 10*#
Table 1. Animal Characteristics
Figure 1. Immunohistochemistry for ERα.  A) Section from a sedentary control rat showing positive staining for ERα pre-
dominantly in the nuclei. B) Section from sedentary diabetic rat illustrates a considerable increase in the ERα positive cells 
with both a nuclear and cytoplasmic distribution of the protein with  more intense levels. Counterstaining was performed 
with hematoxylin.
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[24]. In the rats with diabetes from this study, there was a 
significant increase in the expression of ERα in the endome-
trium. Figure 1 shows two representative fields from control 
sedentary and diabetic sedentary animals. ERα levels were 
analyzed  in  stromal  cells  during  the  mid-secretory  phase 
of the cycle when baseline ERα levels are at their lowest 
[25]. Control tissue had limited ERα staining in the nuclei of 
stromal cells, while sections from diabetic animals showed 
staining in both the cytoplasmic and nuclear regions of the 
cells,  along  with  other  indications  of  proliferation.  Since 
both the amount of immune-reactive tissue and the number 
of ERα-positive cells are important indicators of protein lev-
els, two quantization methods were utilized.  First, the total 
area of ERα staining within each micrograph was calculated 
as a percentage. Figure 2 demonstrates a robust increase in 
the total ERα-stained area in the sedentary diabetic (SD) 
group of animals, which was statistically different from the 
two control groups (p < 0.02). There was greater variation in 
the area of ERα staining in the samples from the sedentary 
diabetic group with some stromal regions reaching as high 
as 82%. Treadmill exercise induced no change in the level 
of ERα in the control groups (comparing sedentary and ex-
ercised controls). The exercise protocol did reduce the area 
stained positive for ERα in the diabetic group, but not to a 
statistically significant level.
    The same trends were noted when micrographs were an-
alyzed for the percentage of cells positive for ERα, while 
this procedure excludes analysis of increased protein levels 
within cells. There was no difference in the percentage of 
cells positive for detectible ERα levels between the seden-
tary and exercised control groups. However, there was a 12% 
increase in the ERα-positive cells in samples from the dia-
betic sedentary compared to the control sedentary group (p < 
0.04). Exercise training reduced the percentage of cells that 
Figure 2. Comparison of estrogen receptor (ERα positive stain-
ing in four groups of rats. Tissue from sedentary control (SC) 
and exercised control (EC) rats illustrated less than 10% of the 
total area that was positive for ERα per region analyzed. Sed-
entary diabetic (SD) animals showed a marked increase in ERα 
immunostaining  (*  indicates  difference  from  the  three  other 
groups, p < 0.02), with exercise training (ED) showing a trend 
towards reversal.
Figure 3. Comparison of p16 positive staining in four groups of 
rats. Tissue from sedentary control (SC) and exercised control 
(EC) rats had a greater area of p16-positive immunostaining. 
Diabetes (SD) reduced the amount of p16-staining when com-
pared to the other three groups (* indicates p < 0.04), while exer-
cise training of the diabetic animals (ED) increased the amount 
of p16 so that it was not statistically different from the control 
groups. (# indicates significant difference between SD and ED).
Figure 4. Histological analysis of endometrial tissue. A) Typical section from a sedentary control rat. B) Typical 
section from a sedentary diabetic rat showing excessive glands (arrows) with tubular cells surrounding the glands, 
along with signs of hyperplasia.
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were ERα-positive in the stromal region of diabetic animals, 
but not to statistically significant levels.
Expression of p16 in the endometrium
The p16 protein, a CDKN2A gene product, is known as a 
tumor suppressor protein. Decreases in the level of p16 have 
been linked with cancer, especially uterine and endometrium 
[26, 27]. Cells with positive staining for p16 from the control 
rats were found to have predominantly cytoplasmic staining 
with little nuclear localization, as described previously [28]. 
In contrast to the increase in the ERα levels in diabetic rats 
in this study, the amount of p16 decreased significantly from 
20% of the total tissue area in the sedentary control group to 
6% in the sedentary diabetic group (Figure 3, p < 0.04). The 
results showed that treadmill exercise training increased the 
area staining positive for p16 in the non-diabetic group from 
20% to 26%, which was not a significant change (p < 0.53). 
In  contrast,  treadmill  exercise  training  had  a  significant 
impact on the p16 levels of the endometrium from diabetic 
rats. The training protocol resulted in an increase in the area 
of positive p16 immunoreactivity from 6% to 17%, which 
was statistically significant (p < 0.04).
Histopathology results
Seventy percent of the specimens analyzed from the sed-
entary diabetic group showed elements of simple glandular 
hyperplasia including excessive endometrial glands. No hy-
perplasia was detected in the control groups or the exercised 
diabetic group. Figure 4 provides examples of stained speci-
men from the two diabetic groups (sedentary and exercised). 
The images show excessive glands and tubular cells with 
large nuclei typical of simple hyperplasia in sections from 
the sedentary diabetic animals. Endometrium from the non-
diabetic  groups  was  comprised  of  healthy  spindle-shaped 
cells.  The  sedentary  control  and  exercise-trained  diabetic 
groups had means of 0.52 ± 0.14 and 0.98 ± 0.26 glands per 
region of interest, respectively (Figure 5). Tissues obtained 
from the sedentary diabetic group had an average of 5.21 ± 
0.75 glands, signifying nearly ten times more glands per area 
when compared to the other groups (p < 0.001). None of the 
sections examined contained tumors.
Discussion
  
Most work linking diabetes to cancer risk has focused on type 
2 diabetes and obesity.  The risk clarified in meta-analysis 
shows a clear increase in mortality from all causes in cancer 
patients who had preexisting diabetes [29]. Specifically the 
prognosis for women with endometrial cancer and diabetes is 
worse than those without diabetes as it correlates to a higher 
rate of lymph node spread and poor overall survival [30]. 
When analyzed for the types of cancer that were a risk factor 
in people with diabetes (type 1 and type 2), endometrial, 
breast  and colorectal cancer were associated with the highest 
risk [29].
      The purpose of this study was to test the link between 
endometrial changes indicative of cancer in a type 1 animal 
model of diabetes, and to determine whether exercise could 
influence the outcome. In this model, there were clearly hy-
perplastic changes in the endometrium of the diabetic ani-
mals. Specifically, the tissue showed excessive glands sur-
rounded by tubular cells with large nuclei, many of them 
positive for excessive ERα.   
Estrogen plays a central role in regulating growth kinet-
ics of a variety of epithelial linings, most importantly in the 
endometrium. Estrogen binds to the estrogen receptor (ERα), 
directly  stimulating  proliferation  and  differentiation.  ERα 
translocates to the nucleus, where it binds to promoter sites 
and thus, regulates the expression of many genes [31]. At 
a cellular level, estrogen has an immense impact on which 
genes are turned on or off, leading to differences in protein 
levels. This is especially true to type I classifications of en-
dometrial carcinomas, which occur most commonly in pre-
menopausal and perimenopausal women and are estrogen 
sensitive [32]. Results described here quantify an increase in 
ERα levels in cells within the endometrium of diabetic rats 
with both the nuclear and cytoplasmic regions staining posi-
tive for the protein.
The p16 has been shown to be an important biomarker 
for cancerous cells in several types of tumors [33]. In fact, 
the location of p16 in the cytoplasm versus nuclear compart-
ments can differentiate between different types of endome-
trial carcinomas [33].  Loss of p16 has been associated with 
Figure 5. Number of glands. The box plot depicts the median 
(bold line within the box) number of glands per region of inter-
est (ROI) within the endometrial stroma and the 25th and 75th 
percentiles (box) between sedentary control, sedentary diabetic 
and exercised diabetic animals. Vertical lines (whiskers) indicate 
the 5th and 95th percentiles with outliers shown by the circles.
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type II endometrial cancer in women [34], and an increased 
rate of metastases [35] and death [36]. Thus, increased lev-
els of p16 in the diabetic animals that were exercise-trained 
and the according absence of endometrial hyperplasia in the 
same group of animals is a significant finding of this study, 
although it does not indicate a cause/effect relationship. 
       The steps linking the pathology of type 1 diabetes to the 
hyperplastic changes noted in the endometrium of sedentary 
diabetic animals is unknown.  Mitochondrial dysfunction is 
one cellular alteration common to diabetes and most cancers 
[37]. It is known that there is extensive cross-talk between 
the  fuel  metabolism  pathways  and  apoptotic  molecules. 
Moreover, unbalanced organelle stress associated with ER 
stress is present in both diabetes and cancer [38, 39]. Since 
type 1 diabetes is an autoimmune disease, altered immune 
function offers another link between the disease and cancer 
with several different immune cells proposed as the culprit 
[40, 41]. 
      An obvious link between diabetes and hyperplasia is in 
the increased glucose availability that is a hallmark of can-
cer cells, and part of the so-called Warburg effect [42-44]. 
It is possible that high glucose levels associated with dia-
betes could have stimulated the hyperplasia noted in the tis-
sue analyzed in this study, although most researchers agree 
that the link between glucose and cellular transformation is 
more complex. Following this line of reasoning, one pos-
sible cause for the prevention of the hyperplastic changes 
in the specimens with exercise training may be due to the 
decreased mean blood glucose levels in the trained animals. 
Table 1 shows a statistically significant 45% decline in the 
blood glucose levels at the end of the four week exercise 
training protocol. Such a decline theoretically could prohibit 
the proliferative phenotype of the cells.  
       In conclusion, the results from the current study showed 
that 1) endometrial estrogen receptors, which can be carci-
nogenic, were present in higher levels with diabetes and that 
exercise training showed a trend to reverse it; 2) levels of 
p16, a known tumor suppressor, were decreased with diabe-
tes, but reversed when the diabetic animals exercised; 3) en-
dometrial hyperplasia was noted in 70% of the samples from 
the sedentary diabetic rats, but not in the exercise trained 
animals.  It is important to note that, although the risk for 
endometrial cancer is greater in patients with type 1 diabe-
tes, the total risk is still low when compared to other more 
common complications of type 1 diabetes. While this study 
found hyperplastic changes in the endometrium of rats with 
uncontrolled type 1 diabetes, no solid tumors were identi-
fied.  The mechanisms linking the systemic influences of 
type 1 diabetes with endometrial hyperplasic and possibly 
endometrial cancer, or any other cancer, are not fully eluci-
dated, but likely include both p16 and the ERα. This area of 
study certainly deserves more attention. The alloxan-injected 
diabetic rat tested in this project provides a suitable animal 
model for further mechanistic studies.
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